For example, in cases where TRPV1 activation drives apoptotic pathways, enhancing its activity could be beneficial, while inhibition might be more effective in situations where TRPV1 supports tumor survival and immune evasion [34]. This evidence concerns the gene TRPV1 and neoplasm.